Baliopharm | Investor profile

Investor info

Type

PE/Buyout

Stage focus

Seed Round

Industry focus

Description

Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.

Previous investments

Company
Amount
Round

Example example company Inc
1000000
Investor meetings
Company & Company
11000000
Series C funding
Example
524000
Seed round A

Connected people

Email visible after logging in

Example Exampleexample[email protected]
Example Exampleexample
Notexample Examplenotexample example[email protected]
Example Examplenotexampleexample example[email protected]
Example Exampleexample[email protected]
Example Exampleexample[email protected]

See other investors focused on

Biotechnology

Other investors you may be interested in

Baruch Future Ventures
Abstract Ventures
AAIPharma Services
AXON Connected
Axxam
Bausch + Lomb
Bavarian Nordic
Bayer
Bayer HealthCare
Bgi-Shenzhen